These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12623305)

  • 1. Effects of amlodipine, atorvastatin and combination of both on advanced atherosclerotic plaque in APOE*3-Leiden transgenic mice.
    van de Poll SW; Delsing DJ; Wouter Jukema J; Princen HM; Havekes LM; Puppels GJ; van der Laarse A
    J Mol Cell Cardiol; 2003 Jan; 35(1):109-18. PubMed ID: 12623305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice.
    van de Poll SW; Delsing DJ; Jukema JW; Princen HM; Havekes LM; Puppels GJ; van der Laarse A
    Atherosclerosis; 2002 Sep; 164(1):65-71. PubMed ID: 12119194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice.
    Delsing DJ; Jukema JW; van de Wiel MA; Emeis JJ; van der Laarse A; Havekes LM; Princen HM
    J Cardiovasc Pharmacol; 2003 Jul; 42(1):63-70. PubMed ID: 12827028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
    Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy.
    Jukema JW; van der Hoorn JW
    Expert Opin Pharmacother; 2004 Feb; 5(2):459-68. PubMed ID: 14996641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-atherosclerotic effect of amlodipine, alone and in combination with atorvastatin, in APOE*3-Leiden/hCRP transgenic mice.
    Trion A; de Maat M; Jukema W; Maas A; Offerman E; Havekes L; Szalai A; van der Laarse A; Princen H; Emeis J
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):89-95. PubMed ID: 16424791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in mice.
    van De Poll SW; Römer TJ; Volger OL; Delsing DJ; Bakker Schut TC; Princen HM; Havekes LM; Jukema JW; van Der Laarse A; Puppels GJ
    Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1630-5. PubMed ID: 11597937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis.
    Martín-Ventura JL; Muñoz-Garcia B; Blanco-Colio LM; Martín-Conejero A; Madrigal-Matute J; Vega M; Ortega L; Serrano J; Egido J
    Kidney Int Suppl; 2008 Dec; (111):S71-4. PubMed ID: 19034332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with atorvastatin and amlodipine suppresses angiotensin II-induced aortic aneurysm formation.
    Takahashi K; Matsumoto Y; Do e Z; Kanazawa M; Satoh K; Shimizu T; Sato A; Fukumoto Y; Shimokawa H
    PLoS One; 2013; 8(8):e72558. PubMed ID: 23967318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.
    Kühnast S; van der Hoorn JW; van den Hoek AM; Havekes LM; Liau G; Jukema JW; Princen HM
    J Hypertens; 2012 Jan; 30(1):107-16. PubMed ID: 22134386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
    Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
    J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice.
    Moustardas P; Kadoglou NP; Katsimpoulas M; Kapelouzou A; Kostomitsopoulos N; Karayannacos PE; Kostakis A; Liapis CD
    PLoS One; 2014; 9(9):e108240. PubMed ID: 25264981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension.
    Zhou MS; Tian R; Jaimes EA; Raij L
    Am J Hypertens; 2014 Jun; 27(6):873-80. PubMed ID: 24413709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of combination therapy with amlodipine and atorvastatin on plasma adiponectin levels in hypertensive patients with coronary artery disease: combination therapy and adiponectin.
    Li M; Xu A; Lam KS; Cheung BM; Tse HF
    Postgrad Med; 2011 Nov; 123(6):66-71. PubMed ID: 22104455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits.
    Niimi M; Keyamura Y; Nozako M; Koyama T; Kohashi M; Yasufuku R; Yoshikawa T; Fan J
    Lipids Health Dis; 2013 Nov; 12():166. PubMed ID: 24188322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.
    Lu JC; Cui W; Zhang HL; Liu F; Han M; Liu DM; Yin HN; Zhang K; Du J
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1110-9. PubMed ID: 19413592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
    Delsing DJ; Offerman EH; van Duyvenvoorde W; van Der Boom H; de Wit EC; Gijbels MJ; van Der Laarse A; Jukema JW; Havekes LM; Princen HM
    Circulation; 2001 Apr; 103(13):1778-86. PubMed ID: 11282910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels.
    Bot I; Jukema JW; Lankhuizen IM; van Berkel TJ; Biessen EA
    Atherosclerosis; 2011 Feb; 214(2):295-300. PubMed ID: 21130458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.